Presentation TCT 2023 Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisaran, and Bempedoic Acid Presenter: Karol Watson October 26, 2023
Presentation TCT 2023 STEMI Pharmacotherapy: Oral and IV Antiplatelet Therapies, Intracoronary Lytic, Anticoagulants, and Early PCSK9 Inhibitors Presenter: Sanjit Jolly October 25, 2023
Presentation ACC 2023 Efficacy and Safety of the Oral PCSK9 Inhibitor, MK-0616, a Macrocyclic Peptide, in the Treatment of Hypercholesterolemia: A Phase 2b Randomized Placebo-Controlled Clinical Trial Presenter: Christie Ballantyne March 05, 2023